Diabetes rates on the rise, developing countries seek solution

Join Our Community of Science Lovers!

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American


Not that long ago many chronic diseases were considered to be problems confined to prosperous countries. But the developing world is fast catching up—especially when it comes to diabetes.

Populous India and China have the most diabetic citizens in the world, with 40.9 million and 39.8 million respectively, according to data from International Diabetes Foundation. Other developing countries, including

Egypt and Suriname, have a higher prevalence of diabetes among adults than the U.S.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


In today’s Boston Globe, reporter Derrick Jackson writes from Uganda about the rise of diabetes there and the struggle for funds to fight the disease.

Bitekyerezo Medaro, a doctor who runs a diabetes clinic in

Mbarara, Uganda, says the number of diagnosed diabetes cases is about the same as HIV (5 to 6 percent of the population).  But the disparity in treatment is stark. Diabetes medicines are expensive; HIV treatments are largely free thanks to aid programs. “One diabetic patient told me she wished she had HIV because HIV treatment is free and she has to pay for insulin," Medaro says.

In 2008, the

U.S. poured $6 billion into AIDS relief through the President’s Emergency Plan for Aids Relief (PEPFAR), and more than 2.1 million people were treated.  Those results leave Medaro split, as he tells the Globe, “When I see the treatment for HIV, I become inspired as to what we can do. When I see what we have for diabetes, I feel defeated.” 

Image courtesy of MelB via Flickr

Correction: The original version of this post misstated the number of people in India and China with diabetes.

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe